Simplify Asset Management has a ways to go to become an industry-standard steward, resulting in a Below Average Parent Pillar rating. Aside from the overall view, portfolio managers at Simplify Asset ...

Kiah Treece is a former attorney, small business owner and personal finance coach with extensive experience in real estate and financing. Her focus is on demystifying debt to help consumers and ...

Tomo’s online rates comparison tool is among the best we’ve seen for shopping rates — and both their rates and fees are competitive. While they don’t offer refinance or home equity options, the solid ...

Dr Reyaz Ahmad                  Math fluency is no longer just about speed in mental calculations or rote memorisation of ...

Julia Kagan is a financial/consumer journalist and former senior editor, personal finance, of Investopedia. Thomas J Catalano is a CFP and Registered Investment Adviser with the state of South ...

Buying, selling, and renting a home has never been a simple process. From deciphering paperwork to managing tenants, the journey from start to finish can take months. But AI is transforming the way ...

Artificial intelligence is changing the game for benefit leaders, improving the benefit selection and delivery process, while simplifying common pain points, too. Processing Content Eighty-one percent ...

CLEVELAND, Ohio -- Find recent home sales and other property transfers in Cuyahoga County with this searchable database. The database includes all sales, as well as ...

Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Doretha Clemons, Ph.D., MBA, PMP, has been a corporate IT executive and ...

Gov. Gavin Newsom pledges action against institutional investors like hedge funds and private equity firms buying homes to rent out, mirroring President Trump’s recent call for similar restrictions.

US Supreme Court to hear 'skinny label' patent fight involving Amarin The U.S. Supreme Court agreed on Friday to hear a patent dispute involving Amarin Pharma's cardiovascular drug Vascepa that could ...